Document is current
Any future updates will be listed below
-
Authors
De, Brian
Khakoo, Yasmin
Souweidane, Mark M.
Dunkel, Ira J.
Patel, Suchit H.
Gilheeney, Stephen W.
De Braganca, Kevin C.
Karajannis, Matthias A.
Wolden, Suzanne L.
-
Funding
Funding for this research was provided by:
National Institutes of Health/National Cancer Institute (P30 CA008748)
Jack and Susan Rudin and the Louis and Rachel Rudin Foundation
- License Information
-
More Information
Article History
Received: 6 September 2017
Accepted: 23 February 2018
First Online: 6 March 2018
Compliance with ethical standards
:
: Ira Dunkel reports personal fees from Bayer Health Care Pharmaceuticals, Ipsen, Celgene, and Apexigen, and grants from Genentech and Parexel (GSK, Novartis), all outside the submitted work. Dr. Souweidane reports personal fees from Aesculap outside the submitted work. All other authors declare no conflicts.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: For this type of study, formal consent is not required.
